Annual report pursuant to Section 13 and 15(d)

WARRANTS TO PURCHASE COMMON STOCK

v3.20.4
WARRANTS TO PURCHASE COMMON STOCK
12 Months Ended
Dec. 31, 2020
Warrants To Purchase Common Stock [Abstract]  
WARRANTS TO PURCHASE COMMON STOCK

NOTE 13 – WARRANTS TO PURCHASE COMMON STOCK

 

The following table summarizes information with respect to outstanding warrants to purchase common stock of the Company at December 31, 2020:

 

Exercise     Number     Expiration
Price     Outstanding     Date
$ 0.50       24,920       November 2024  
$ 0.57       126,900       February 2025  
$ 35.00       490,571       December 2023  
$ 630.00       5,441          October 2021  
$ 687.50       474          October 2021  
          648,306          

 

During the year ended December 31, 2020, 2.3 million warrants from the November 2019 financing, with an exercise price of $0.57, were exercised for proceeds of approximately $1.3 million. During the year ended December 31, 2020, 2.3 million warrants from the November 2019 financing, with an exercise price of $0.50, were exercised for proceeds of approximately $1.2 million.

 

During the year ended December 31, 2020, 13.0 million warrants from the February 2020 financing, with an exercise price of $0.57, were exercised for proceeds of approximately $7.5 million.

 

During the year ended December 31, 2020, 2,500 warrants with a per share exercise price of $0.50 expired.

 

During the year ended December 31, 2019, 2,000 warrants with an exercise price of $35.00 were exercised for proceeds of approximately $70,000.

 

During the year ended December 31, 2019, 24 warrants with a per share exercise price of $25,000 expired.